Re: Givin up on Doctors

In article <srr6r2dbs2bq0d2pknol2gtamiu7gam1h2@xxxxxxx>,
Port@xxxxxxxxxxxxxx wrote:

Port wrote:
I know, I
know, lose the VAT... but WHAT VAT?).

"Andrew B. Chung, MD/PhD" wrote:
The VAT that is located intraabdominally increasing the waistline.

Thanks but .... I was just whining.
If it's there, it's very hard to see :-(

Port

Nothing wrong with a little whining! Five and stenting even when you
know what is involved. Whew a strong man.

Found this which seems contrary.

Jim, what does monotonically decreasing mean?

Bill four and no stents.

....................


CONCLUSIONS: In CHF patients a higher BMI is associated with a better
prognosis independently of other clinical variables. The relationship
between mortality and BMI is monotonically decreasing.

1: Eur J Heart Fail. 2006 Dec 11; [Epub ahead of print]
Links
Body mass index, prognosis and mode of death in chronic heart failure:
Results from the Valsartan Heart Failure Trial.
? Cicoira M, Maggioni AP, Latini R, Barlera S, Carretta E, Janosi A,
Soler Soler J, Anand I, Cohn JN; on behalf of Val-HeFT Investigators.
Department of Biomedical and Surgical Sciences, Section of Cardiology,
University of Verona, Piazzale Stefani, 1-Verona, Italy.
AIMS: To assess the relationship between body mass index (BMI),
mortality and mode of death in chronic heart failure (CHF) patients; to
define the shape of the relationship between BMI and mortality. METHODS
AND RESULTS: We performed a post-hoc analysis of 5010 patients from the
Valsartan Heart Failure Trial. The end-points of the study were
all-cause and cardiovascular mortality. Mortality rate was 27.2% in
underweight patients (BMI<22 kg/m(2)), 21.7% in normal weight patients
(BMI 22-24.9 kg/m(2)), 17.9% in overweight patients (BMI 25-29.9
kg/m(2)) and 16.5% in obese patients (BMI>30 kg/m(2)) (p<0.0001). The
rates of non-cardiovascular death did not differ among groups. The risk
of death due to progressive heart failure was 3.4-fold higher in the
underweight than in the obese patients (p<0.0001). Normal weight,
overweight and obese patients had lower risk of death as compared with
underweight patients (p=0.019, HR 0.76, 95% CI 0.61-0.96; p=0.0005, HR
0.68, 95% CI 0.55-0.84; p=0.003, HR 0.67, 95% CI 0.52-0.88,
respectively) independently of symptoms, ventricular function,
beta-blocker use, C-reactive protein and brain natriuretic peptide
levels. CONCLUSIONS: In CHF patients a higher BMI is associated with a
better prognosis independently of other clinical variables. The
relationship between mortality and BMI is monotonically decreasing.
PMID: 17166768 [PubMed - as supplied by publisher]

--

S Jersey USA Zone 5 Shade
http://www.ocutech.com/ High tech Vison aid
This article is posted under fair use rules in accordance with
Title 17 U.S.C. Section 107, and is strictly for the educational
and informative purposes. This material is distributed without profit.
.

Relevant Pages
Loading